Financhill
Back

Plus Therapeutics Stock Predictions

Plus Therapeutics Stock Forecast

  • Is Plus Therapeutics Stock Undervalued?
    The current Plus Therapeutics [PSTV] share price is $1.63. The Score for PSTV is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • PSTV is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Plus Therapeutics Stock Go Up Next Year?

Data Unavailable

Plus Therapeutics Stock Rating

Data Unavailable

Plus Therapeutics Stock Price History

Is PSTV stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
plustherapeutics.com

52-Week Data

52-Week High:
5.09
52-Week Low:
0.97

Prediction Charts

Market Cap:
7.1M
Price in USD:
1.63
Volume:
17.18K
Beta:
1.34

Technical Analysis

SMA50:
1.85
SMA100:
1.91
SMA200:
1.88
52-Wk Change:
-58.84%

Stock Predictions

  • Is Plus Therapeutics stock public?
    Yes, Plus Therapeutics is a publicly traded company.
  • What is the Plus Therapeutics stock quote today?
    The Plus Therapeutics stock price is 1.63 USD today.
  • How to buy Plus Therapeutics stock online?
    You can buy Plus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-4 1.87 1.92 1.97 1.87
Apr-5 1.94 1.88 1.97 1.83
Apr-8 1.86 1.89 1.89 1.82
Apr-9 1.87 1.84 1.87 1.84
Apr-10 1.81 1.88 1.88 1.73
Apr-11 1.85 1.87 1.91 1.78
Apr-12 1.81 1.86 1.90 1.80
Apr-15 1.82 1.74 1.93 1.73
Apr-16 1.74 1.75 1.86 1.74
Apr-17 1.80 1.77 1.80 1.67
Apr-18 1.74 1.69 1.79 1.69
Apr-19 1.77 1.66 1.77 1.63
Apr-22 1.63 1.66 1.75 1.54
Apr-23 1.61 1.63 1.69 1.61

Plus Therapeutics Earnings

Data Unavailable

Plus Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.04 per share, an increase this year of $2.58 per share, and an increase next year of $0.41 per share.

* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.